Seroprevalence of SARS-CoV-2 (COVID-19) among Health Care Workers in Three Health Facilities of Yaounde, Center Region of Cameroon



Abstract Views
886

Downloads
462

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Oct 15, 2021
Published Dec 13, 2021
10.24018/ejmed.2021.3.6.1109

Abstract viewed = 886 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Introduction: Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first appeared in December 2019 in Wuhan, China and has subsequently become a worldwide pandemic. During the pandemic, health care workers (HCWs) were very exposed to COVID-19 infected patients. The aim of this study was to determine seroprevalence of SARS-CoV-2 (COVID-19) among HCWs in three health facilities of Yaounde.

Methods: A cross-sectional study involving 368 HCWs was conducted from January 18th to February 13th, 2021, in three health facilities located in city of Yaounde. Data of study participants were collected by face-to-face interviews using standard questionnaire. Blood samples were collected in labelled dry tubes and analyzed using Rapid Diagnostic Test (RDT) cassettes (Abbott PanbioTMCOVID-19 IgG/IgM Rapid Test Device). The data collected was analyzed using Epi info version 7. Any value of p <0.05 was considered statistically significant.

Results: The average age was 30.25 (SD±10.43) years old, range from 21 to 72 years old. Overall, the positivity rates of IgM, IgG and IgM+IgG were 6.79% (n=25), 17.93% (n=66) and 1.09% (n=4) respectively. Multivariate analysis showed that, the rate of IgM positivity was highest in laboratory personnel (χ2= 7.99, p=0.3) and IgG (χ2= 8.50, p=0.29), IgM+IgG (χ2= 1.92, p=0.26) respectively in pharmacy and clinical personnel. The clinical signs such as fever (˃38°C) or history of fever was statistically significant with IgM (χ2=11.71, p= 0.0006) while, sore throat was statistically significant associated with IgM (χ2= 14.3, p= 0.0008) and IgG (χ2= 6.33, p= 0.04).

Conclusion: The results of this study reveal a high seroprevalence of circulation of the virus in hospital milieu in Yaounde suggesting the continuation of the COVID-19 « Track-Test-Treat » system to break the chain of transmission.

Keywords: Health care workers, seroprevalence, SARS-CoV-2, Yaounde

Downloads

Download data is not yet available.

References

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. Journal of Medical Virology. 2020; 92(4): 401.
    DOI  |   Google Scholar
  2. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomedica. 2020; 91(1): 157-160.
     Google Scholar
  3. World Health Organization. Coronavirus disease (COVID-19). [Online] 2020 [cited on: 2020 October 11].
     Google Scholar
  4. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; in press [https://doi.org/10. 1001/jamainternmed.2020.0994].
     Google Scholar
  5. Johns Hopkins University. Coronavirus Covid-19 Global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). [Online] Available from: https://coronavirus.jhu.edu/map.html
     Google Scholar
  6. WHO. Rapport de situation épidémiologique du SARS-CoV-2 [Online] 2021 [cited on: 2021 February 26]. Available from : https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.
     Google Scholar
  7. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223): 514–23.
    DOI  |   Google Scholar
  8. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal Medicine. 2020; 382: 970–971.
    DOI  |   Google Scholar
  9. CCOUSP. Stratégies nationales de diagnostic et de dépistage de la COVID-19 au cameroun. [Online] 2020.
     Google Scholar
  10. Chersich MF, Gray G, Fairlie L, Eichbaum Q, Mayhew S, Allwood B et al. COVID-19 inAfrica: care and protection for frontline healthcare workers. Global Health. 2020; 16(1): 46.
    DOI  |   Google Scholar
  11. OMS. Utilisation rationnelle des équipements de protection individuelle (EPI) contre la maladie à coronavirus 2019 (COVID-19) et éléments à considérer en cas de grave pénurie consulté le 4 Avril. [Online] 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/331765/WHO-2019-nCov-IPC_PPE_use2020.3-fre.pdf.
     Google Scholar
  12. Wei JT, Liu ZD, Fan ZW, Zhao L, Cao WC. Epidemiology of and risk factors for COVID-19 infection among health care workers: a multi-centre comparative study. International Journal of Environmental Research and Public Health. 2020;17(19): 7149.
    DOI  |   Google Scholar
  13. Ağalar C, Öztürk Engin D. Protective measures for COVID-19 for healthcareproviders and laboratory personnel. Turkish Journal of Medical Sciences. 2020; 50(SI-1): 578-84.
    DOI  |   Google Scholar
  14. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. The Lancet Global Health. 1 avril ;8(4): e48
    DOI  |   Google Scholar
  15. Xiao J, Fang M, Chena Q, He B. SARS, MERS and COVID-19 among healthcare workers: a narrative review. 2020; 13(6): 843-848.
    DOI  |   Google Scholar
  16. Katchunga PB, Murhula A, Akilimali P, Zaluka JC, Karhikalembu R, Makombo M, et al. Séroprévalence des anticorps anti-SARS-CoV-2 parmi les voyageurs et travailleurs dépistés à la clinique Saint Luc de Bukavu, à l´ Est de la République Démocratique du Congo, de mai en août 2020. The Pan African Medical Journal. 2021: 38. French.
     Google Scholar
  17. Nguépy KFR, Mboua PC, Tadongfack DT, Tchoffo FE, Tatang TC, Zeuna JI, et al. Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales Médico-Psychologiques. 2021; 179: 141–146.
    DOI  |   Google Scholar
  18. Fai KN, Corine TM, Bebell LM, Mboringong AB, Nguimbis EBPT, Nsaibirni R, et al. Serologic response to SARS-CoV-2 in an African Population. Scientific African, 2021; e00802.
    DOI  |   Google Scholar
  19. Batra R, Olivieri LG, Rubin D, Vallari A, Pearce S, Olivo A, et al. A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay. Journal of Clinical Virology. 2020; 132.
    DOI  |   Google Scholar
  20. Suarez-Garcıa I, Martınez de Aramayona Lopez MJ, Saez Vicente A, Lobo Abascal P. SARS-CoV-2 infection among healthcare workers in a hospital in Madrid, Spain. Journal of Hospital Infection 106 (2020) 357e363. Available online at www.sciencedirect.com
    DOI  |   Google Scholar
  21. Moscola J, Sembajwe G, Jarrett M, Farber B, Chang T, Thomas McGinn T, et al. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area. JAMA. 2020; 324(9): 893-895.
    DOI  |   Google Scholar
  22. Schneider S, Piening B, Pauline Pasovsky A.N, Krüger AC, Gastmeier P, and Aghdassi SJS. SARS‑Coronavirus‑2 cases in healthcare workers may not regularly originate from patient care: lessons from a university hospital on the underestimated risk of healthcare worker to healthcare worker transmission. Antimicrob Resist Infect Control (2020) 9:192. https://doi.org/10.1186/s13756-020-00848-w
    DOI  |   Google Scholar
  23. Olivier C, Bouvet E, Abiteboul D, Lolom I, Pellissier G, Delarocque-Astagneau E. et al. Contexte de contamination des professionnels de santé par la COVID-19 : résultats préliminaires. Médecine et Maladies Infectieuses. Sept 2020; 50(6, Supplement): S71. French.
    DOI  |   Google Scholar


Most read articles by the same author(s)